Dr. Sebastian Beil is a Research Fellow and Group Leader at the Max Planck Institute for Chemical Energy Conversion (MPI CEC) in Mülheim an der Ruhr, Germany, leading the 'Electrosynthesis and Photocatalysis' group since 2024. He holds a B.Sc. and M.Sc. from Christian Albrechts University of Kiel (2010–2015), a Ph.D. from Johannes Gutenberg University Mainz (2015–2019), and completed postdoctoral research at the University of Ulm (2019–2020) and Princeton University (2020–2021). He was an Assistant Professor at the University of Groningen (2021–2024) before joining MPI CEC. His research focuses on developing sustainable redox transformations using visible light or electrodes, combined with transition metal catalysis to synthesize complex molecules efficiently. The lab’s work bridges organic chemistry and electrochemistry, emphasizing green solvents and scalable methods. Recent research highlights include advancements in nickel-photocatalytic reactions, functionalization of carbon nanotubes, and mechanistic studies of energy transfer in photocatalytic systems. The team collaborates across disciplines, addressing challenges in catalyst design and reaction efficiency. Key team members include PhD students Annemijn van Koten (Unilever Prize awardee), Rani Kumari, Tim Stamp, Berjan Stouwie, Ning Wei, and Mahdi Samapour, along with postdoc Zeyu Feng. The lab is part of the broader Waldvogel Lab network, fostering interdisciplinary innovation in electrosynthesis.
Fabian Pfrengle is a full Professor of Organic Chemistry at the Institute of Organic Chemistry , Department of Natural Sciences and Sustainable Resources , University of Natural Resources and Life Sciences Vienna (BOKU). He previously led research groups at the Max Planck Institute of Colloids and Interfaces (2013-2020) and worked at The Scripps Research Institute (2010-2013). Research Focus: His work bridges carbohydrate chemistry and plant biology , specializing in plant cell wall glycans and glycosyltransferases . He develops synthetic glycan arrays for enzyme characterization and investigates immune response triggering mechanisms in plants through oligosaccharide fragments . His projects include automated polysaccharide synthesis and liposome-based immune tolerance applications. Publication Trends: His 15 most recent articles emphasize chemical synthesis of sugar nucleotides , plant glycan arrays , and enzyme specificity analysis , reflecting his focus on carbohydrate engineering and plant immunity . Key subfields include UDP-sugar derivatization , Xylan structure-function relationships , and Glycosyltransferase profiling . Grants & Projects: Currently leads 5 major projects including Automated Algal Polysaccharide Synthesis (EU-funded, 2023-2028) and Synthetic Glycan Ligands for Plant Immune Receptors (FWF-funded, 2022-2026). His research also explores thrombocyte biology and Rhamnogalacturonan-II fragments with support from FWF and City of Vienna . Community Service: Serves on editorial boards ( Monatshefte für Chemie , 2021-present) and as reviewer for 12 journals including JACS Au , Nature Communications , and Angewandte Chemie . Member of professional societies: Gesellschaft Österreichischer Chemiker (2020), Deutscher Hochschulverband (2019), and Gesellschaft Deutscher Chemiker (2008).
Scott Garman is Professor of Biochemistry at UMass Amherst, focusing on structural biology of glycoproteins in human diseases. PhD from Harvard University. Research areas: Lysosomal enzyme mechanisms in storage diseases (Fabry, Schindler); Malaria surface protein structures; Antibody-receptor interactions. Utilizes X-ray crystallography to study enzyme mutations causing disease. Key findings: Determined structures of α-galactosidase (Fabry disease) and α-NAGAL (Schindler disease), revealing molecular bases for enzyme dysfunction. Developed models for enzyme trafficking and substrate processing. Laboratory: Investigates protein folding diseases and develops therapeutic strategies. Collaborates on malaria vaccine development and antibody engineering.
Professor Roland J. Pieters is a distinguished academic at Utrecht University's Faculty of Science, where he serves as a full Professor in the Department of Chemical Biology and Drug Discovery. With over two decades of experience at the institution, he has progressed from Assistant Professor (1998) to Associate Professor (2005) and ultimately to Full Professor (2010-present). His research group is internationally recognized for groundbreaking work at the intersection of carbohydrate chemistry, chemical biology, and drug discovery, with particular emphasis on developing novel therapeutic approaches against bacterial infections and pathogenic mechanisms. Full Professor, Utrecht University (2010-present) Associate Professor, Utrecht University (2005-2010) Assistant Professor, Utrecht University (1998-2005) NWO Talent Post-doctoral Fellow, ETH-Zürich (1995-1996) Postdoctoral Researcher, University of Groningen (1996-1998) Professor Pieters earned his M.Sc. in Organic Chemistry from the University of Groningen in 1990, where he worked with Professor Ben Feringa, and completed his Ph.D. at MIT in 1995 under the supervision of Professor Julius Rebek Jr. His doctoral research focused on molecular recognition and template effects in bisubstrate systems, establishing the foundation for his lifelong interest in molecular interactions. Professor Pieters' research primarily centers on glycodrugs and the strategic interference with protein-carbohydrate interactions using multivalent systems of varying architectures. His laboratory has made significant contributions to understanding how rigid spacers in multivalent ligands can dramatically enhance binding affinity to target proteins, with applications against viral and bacterial adhesion proteins, toxins, galectins, and glycosidases. A particular focus has been on developing inhibitors for Pseudomonas aeruginosa lectin LecA, cholera toxin, influenza virus hemagglutinin, and more recently, SARS-CoV-2 spike protein interactions with host cell receptors. His group also pioneered the use of glyco- and peptide-microarrays for high-throughput screening of carbohydrate-protein interactions and drug discovery, particularly in the area of O-GlcNAcylation research. The publication record of Professor Pieters demonstrates consistent innovation in the field of multivalent carbohydrate-based therapeutics. His recent work (2020-2024) shows a strategic expansion into viral pathogenesis (particularly influenza and SARS-CoV-2), immune modulation through glycan recognition, and novel approaches to vaccine development. A notable trend is the increasing sophistication of multivalent architectures, moving from simple divalent systems to tetra- and hexavalent ligands with precisely engineered spatial arrangements. His research bridges fundamental chemical principles with practical therapeutic applications, maintaining strong connections to pharmaceutical development while advancing basic science understanding of carbohydrate-mediated biological processes. Professor Pieters' scientific achievements have been recognized with prestigious awards including a Fellowship from the Royal Netherlands Academy of Arts and Sciences (KNAW) in 1999 and a VICI personal grant from the Netherlands Organisation for Scientific Research (NWO) in 2008. These competitive awards reflect the significance and innovation of his research program. He has also served on editorial advisory boards, notably as Section Editor-in-Chief for Chemical Biology in the journal Molecules (2018-2022), contributing to the scholarly community through peer review and academic leadership. Fellowship of Royal Netherlands Academy of Sciences (KNAW), 1999 VICI, personal grant, NWO, 2008 Section Editor-in-Chief Chemical Biology for Molecules (2018-2022) Throughout his career, Professor Pieters has coordinated significant research projects including the EU project POLYCARB and secured competitive funding that has sustained his innovative research program. His laboratory has fostered numerous collaborations across Europe and internationally, creating a vibrant research environment that has trained many scientists now working in academia and industry. His research on multivalent carbohydrate systems represents a sustained intellectual contribution to chemical biology with direct relevance to developing new anti-infective strategies and therapeutic approaches. Professor Pieters leads an active research group within Utrecht University's Department of Chemical Biology and Drug Discovery, situated in the David de Wied Building. His laboratory maintains strong connections with other research groups both within Utrecht University and internationally, particularly in the fields of glycobiology, infectious diseases, and drug discovery. The research environment he has cultivated emphasizes interdisciplinary approaches, combining synthetic chemistry, biophysical analysis, and biological testing to address fundamental questions in carbohydrate-mediated biological processes with therapeutic applications.
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Dr. Martin Anthony Fascione is a Reader in Chemistry at the University of York, where he leads the Fascione Lab within the Department of Chemistry. His research focuses on the interface between chemistry and biology, particularly in the field of chemical glycobiology. He has established himself as a leading researcher in carbohydrate chemistry with expertise in synthetic methods and biological applications. Dr. Fascione received his Ph.D. from the University of Leeds in 2009 under the supervision of W. Bruce Turnbull, followed by a Marie Curie International Outgoing Fellowship at the University of British Columbia with Prof. Steve Withers and the University of York with Prof. Gideon Davies. Since August 2014, he has been at the York Structural Biology Laboratory, progressing from Lecturer to his current position as Reader. His research centers on complex sugars (glycans) and their roles in biological processes and disease, with particular emphasis on sialic acid-like molecules critical for bacterial pathogens. The Fascione group develops chemical tools to study and perturb glycan activity in vivo using synthetic and enzymatic carbohydrate chemistry, organocatalysis, enzymology, and molecular biology. Key research areas include pseudaminic acid biosynthesis, protein bioconjugation, and glycoconjugate development for therapeutic applications. Analysis of Dr. Fascione's recent publications reveals a strong focus on bacterial glycans, particularly pseudaminic acid, and their role in pathogenesis. His work combines synthetic chemistry with biological applications, developing novel methods for protein modification, carbohydrate synthesis, and glycan-based therapeutics. Major themes include bioorthogonal chemistry, enzymatic synthesis of complex carbohydrates, and the development of glycoconjugates for therapeutic and diagnostic applications. Dr. Fascione has received significant recognition for his work, including: Marie Curie International Outgoing Fellowship (2012-2014) ERC Consolidator Grant (2022) As an active researcher, Dr. Fascione supervises PhD students and collaborates extensively with researchers in the UK and internationally. His laboratory is involved in multiple research projects focused on chemical glycobiology for infectious disease research and therapeutic development. The Fascione Lab has established itself as a leading center for research at the chemistry-biology interface, with particular expertise in carbohydrate-active enzymes and glycan-based tools for biological investigation.
Dr. Liang Yu is an Adjunct Professor at Washington State University (WSU) within the College of Agricultural, Human, and Natural Resource Sciences (CAHNRS), Department of Biological Systems Engineering. He holds roles as a Guest Editor for the Journal of Fermentation (Energy Converter-Anaerobic Digestion), Faculty Senator for Non-Tenure Track Faculty, Anti-Hazing Advisory Committee member, and Review Committee member for undergraduate research scholarships at WSU. His research focuses on biorefinery-based industrial symbiosis and the circular economy, employing multi-scale mathematical modeling (molecular simulation, CFD, bioprocess control, machine learning) to optimize anaerobic digestion systems. His work aims to convert organic waste (animal manure, food waste) into renewable natural gas, fertilizers, and bioproducts. He has secured funding from the DOE and USDA, with over 60 peer-reviewed publications and five patents. Key research themes include hydrothermal pretreatment, ammonia recovery, microbial community dynamics, and techno-economic analysis. Recent articles emphasize anaerobic digestion innovation, biodesulfurization, and biohydrogen production. His contributions bridge environmental engineering, biotechnology, and sustainable systems design. Dr. Yu’s grants and patents reflect a commitment to applied sustainability solutions, with projects addressing agricultural waste valorization and energy recovery. Collaborative efforts drive his work, integrating computational modeling with experimental validation for scalable bioenergy systems.
Pedro Carlos De Barros Fernandes is an Associate Professor at Universidade Lusófona , Deputy Director of the 1st cycle in Biotechnology, and an integrated researcher at the Institute of Bioengineering and Biosciences (iBB-IST). He holds a PhD in Biotechnology (1999) and a Master in Biotechnology/Biochemical Engineering (1994) from Universidade Técnica de Lisboa (IST), along with a Chemical Engineering degree from IST (1989). A member of the Order of Engineers (ID 24667), he co-founded Biotrend, a Portuguese bioprocess development company. Education PhD in Biotechnology (1999), Universidade Técnica de Lisboa MSc in Biotechnology (1994), Instituto Superior Técnico BSc in Chemical Engineering (1989), Instituto Superior Técnico Research Interests span biocatalysis, enzyme immobilization for food and pharmaceutical applications, marine biotechnology, microfluidic device development for biosensing, and steroid bioconversions using mycobacterial systems. His work integrates process engineering principles with sustainable bioprocessing techniques. Publication Trends show a focus on microreactor technology, enzyme stabilization in non-conventional media, marine-derived biocatalysts, and food waste valorization. Key themes include biocatalytic process intensification, aqueous two-phase systems for biomolecule purification, and sustainable carbon sources for biopolymer production. Scientific Awards UTL/Santander Totta Scientific Award in Biological Engineering (2011) Advising has included supervision of 5 doctoral theses and over 32 master’s theses. His expertise extends to peer-reviewing scientific articles and evaluating R&D projects. Labs & Teams are associated with iBB-IST (Institute of Bioengineering and Biosciences) and BioRG (Universidade Lusófona), with contributions to the Ciência Viva program for science dissemination.
Bert F. Sels is a Full Professor at KU Leuven (Catholic University Leuven) in the Faculty of Bioscience Engineering, Department of Molecular and Microbiological Sciences, where he founded and heads the Center for Sustainable Catalysis and Engineering (CSCE). He is also a Visiting Professor at the Chinese Academy of Sciences in Guangzhou and co-founder of the spin-off company Zeopore. Previously, he directed the Centre for Surface Chemistry and Catalysis (COK) from 2016-2019 and served as Head of the Division Bio-refinery and Sustainable Chemistry (2015). He obtained his Ph.D. in 2000 from KU Leuven under Professor Pierre Jacobs, specializing in heterogeneous oxidation catalysis. His research focuses on heterogeneous catalysis for sustainable industrial processes, with expertise spanning: Biorefinery and biofactory systems for chemical production Design of hierarchically structured zeolites and carbon materials Spectroscopic characterization of catalytic active sites Methane activation and small molecule kinetics Renewable chemistry and biomass valorization His group has published 350+ papers (h-index 88) and holds 30 patents. Publications demonstrate strong focus on catalytic biomass conversion, zeolite engineering, and sustainable fuel production, with recent work emphasizing lignin valorization, carbohydrate upgrading, and low-carbon chemical synthesis. Key trends include hierarchical catalyst design and integrated biorefinery processes. Awards and Honors: Green Chemistry Award (2015) INEOS Research Award (2019) European Academy of Sciences and Arts Membership (2018) DSM Chemistry Award (2001) TOTAL Research Award (2013) UMICORE Research Award (2012) First Clean Tech Challenge (2009) He leads the CSCE research group and co-founded the European Research Institute of Catalysis (ERIC). As former co-chair of the International Zeolite Association's Catalysis Commission and associate editor of ACS Sustainable Chemistry & Engineering, he maintains extensive collaborative networks.
Shabaz Mohammed is an Associate Professor of Proteomics at the University of Oxford, holding joint appointments in the Departments of Chemistry and Biochemistry. Since 2020, he has served as Head of the Mechanistic Proteomics research programme at the Rosalind Franklin Institute. His research focuses on advancing proteomics technologies to study protein post-translational modifications and their roles in cellular processes, with applications in viral infections and disease mechanisms. Education: BSc in Chemistry, UMIST (now The University of Manchester), 1999 PhD in Biological Mass Spectrometry, University of Manchester, 2003 Postdoctoral Research, University of Southern Denmark (with Ole Jensen), 2005-2008 Postdoctoral Research, Utrecht University (with Albert Heck), 2008 Professor Mohammed's research centers on developing novel mass spectrometry approaches for large-scale characterization of protein post-translational modifications (PTMs). His group innovates in chromatographic techniques for single-cell proteomics, creates materials for PTM enrichment (glycosylation/phosphorylation), and applies these tools to study viral infections (SARS-CoV-2), cell cycle regulation, and signaling pathways. His work bridges chemistry, biochemistry, and cell biology to understand dynamic protein functions in health and disease. His recent publications (2023-2025) demonstrate strong emphasis on viral proteomics, particularly virus-host RNA-binding protein interactions, and innovations in mass spectrometry fragmentation techniques and chromatography. Key themes include viral remodeling of host cells, new labeling strategies for PTMs, and advancements in single-cell proteomics, with significant implications for understanding viral pathogenesis. Scientific Awards: No specific awards or fellowships were detailed in the source material. Advising and Grants: Information regarding graduate students supervised or specific research grants was not provided in the available text. As an active research group leader, Professor Mohammed likely mentors PhD students and secures competitive funding for proteomics research. Laboratories and Collaborations: Professor Mohammed leads a research group at Oxford focused on proteomics technology development. He collaborates extensively with the Ben Davis group on PTM detection materials and across the university on biochemical applications. At the Rosalind Franklin Institute, he heads the Mechanistic Proteomics programme to unravel protein functions through advanced proteomic methods.
Lailiang Cheng is a Professor in the Horticulture Section of Cornell University's School of Integrative Plant Science, specializing in the physiological processes of deciduous fruit crops (particularly apple). His research focuses on sugar/malate metabolism, mineral nutrition, and environmental stress responses to improve orchard productivity and fruit quality. He integrates physiological, biochemical, and molecular approaches to study sorbitol signaling and nutrient management in high-density orchards. Education: Doctorate, Oregon State University (1999) Master of Science, Shandong Agricultural University (1989) Bachelor of Science, Shandong Agricultural University (1984) Research Focus: Cheng's work investigates carbon partitioning, malate accumulation, and nutrient transport dynamics in apple trees under abiotic stresses. His extension program delivers nutrient management strategies to the apple industry, while his teaching emphasizes analytical techniques (PLSCI 6170) and crop nutrition principles (PLSCI 4551/6551). Publication Analysis: Recent articles (2021-2025) reveal dominant themes in molecular regulation of fruit acidity, transporter biology, stress-responsive transcription factors, and omics-assisted breeding. Over 70% of publications involve collaborative work on apple genomics, with consistent emphasis on translating basic research into orchard management solutions. Awards & Recognition: No scientific awards mentioned in source materials. Academic Contributions: Advises graduate students in Horticulture; research supported by Cornell University Agricultural Experiment Station. Collaborates extensively with pomology breeders, extension specialists, and molecular biologists globally.
Dr. Michael Philben is an Associate Professor of Chemistry and Geological and Environmental Science at Hope College, where he joined in 2019 after postdoctoral positions at Memorial University (Canada) and Oak Ridge National Laboratory. His research focuses on climate-carbon cycle feedbacks in vulnerable ecosystems, particularly peatlands and Arctic tundra. His educational background includes a Ph.D. in Marine Science from the University of South Carolina (2014) and a B.A. in Earth and Planetary Science from Northwestern University (2010). At Hope College, he teaches Environmental Science courses and contributes to the Day1: Watershed program. Philben's research centers on carbon and nitrogen cycling in ecosystems containing vast organic carbon stocks. He leads an NSF CAREER-funded project investigating Michigan peat bogs as natural laboratories for climate change impacts, using a north-south transect from Portage to Newberry as a 'space-for-time' experiment. His work examines methane emissions, nitrogen availability, and net carbon balance under warming conditions, with particular attention to Sphagnum-dominated peatlands at the southern edge of their climate range. His 15 most recent publications (2020-2024) reveal a strong focus on peatland biogeochemistry, with increasing emphasis on methane dynamics, nitrogen cycling, and the role of specific biochemical compounds like sphagnan. The research combines field measurements across climate gradients with laboratory experiments, often involving Hope College students in all project phases. NSF CAREER Award for peatland climate research Philben actively mentors undergraduate researchers through the Philben Research Group, which investigates how warming impacts carbon cycling in peatlands. His projects involve interdisciplinary work spanning analytical chemistry, geology, and ecology. The group maintains a network of seven Michigan peat bog field sites and collaborates on international research, including Arctic studies in Alaska and Canada. His laboratory focuses on using analytical chemistry tools to predict climate-carbon cycle feedbacks, with particular attention to southern Michigan peatlands as sentinels for larger northern peatland complexes. The research group employs techniques including greenhouse gas flux measurements, radiometric dating of peat cores, and analysis of organic matter composition.
Koenraad Muylaert is a Full Professor at the Faculty of Science, KU Leuven, and head of the Biology department at KU Leuven Kulak. His research focuses on microalgae ecology and phytoplankton physiology , with applications in eutrophication studies , wastewater treatment , and biofuel production . Based in Kortrijk, Belgium, he works with international teams in Ecuador, Qatar, and Belgium. Current projects on mountain lake eutrophication and urban aquatic systems Specializes in nano-material flocculation and omega-3 fatty acid production from microalgae Research Trends from his recent articles show emphasis on: Microalgae harvesting innovations (cellulose nanocrystals, PDMAEMA polymers) Comparative processing techniques (DAF vs sedimentation, drying methods) Biotechnological applications in flavor chemistry and microbiome interactions Laboratory operates at KU Leuven's Kortrijk campus, with strong collaborations in environmental engineering and food science . His work bridges fundamental ecological research with industrial biotechnology for sustainable solutions.
Mario M. Martinez is an Associate Professor and Sapere Aude Research Leader at the Department of Food Science, Aarhus University. His research focuses on translational glycoscience, investigating the structure-function relationships of food polysaccharides, their interactions with plant secondary metabolites, and applications in plant-based food structuring technologies (e.g., extrusion processing) and biodegradable packaging solutions. Awards: CEPS Assistant Professor Research Excellence Award Young Scientist Research Award (AACCI) Ontario Early Researcher Award Nils Foss Talent Prize Sapere Aude Research Leader Fellowship Martinez serves as Adjunct Assistant Professor at Purdue University's Whistler Center for Carbohydrate Research and is a member of the Editorial Advisory Board for ACS – Food Science and Technology . His work bridges biochemical complexity with practical food innovation.
Professor Gavin J. Miller is a Professor of Biological Chemistry at Keele University, UK, affiliated with the Lennard-Jones School of Chemical and Physical Sciences. He holds a MChem from UMIST and a PhD in carbohydrate chemistry from the University of Manchester. His research focuses on glycoscience at the chemistry-biology interface, with expertise in synthesizing carbohydrates and nucleosides using chemoenzymatic and biocatalytic methods. He leads the Miller Research Group, which explores biomolecule synthesis for chemical biology applications and medicinal chemistry. Education BSc Chemistry (Medicinal Chemistry focus) – UMIST PhD in Carbohydrate Chemistry – University of Manchester Research Interests Professor Miller’s work emphasizes synthetic approaches to heparan sulfate oligosaccharides, nucleoside analogs, and glycoconjugates. His group develops scalable methods for glycan assembly and explores applications in antiviral therapies, cancer drug design, and SARS-CoV-2 interaction studies. Key areas include: Chemoenzymatic synthesis of glycoconjugates Biocatalytic nucleotide production Structural glycoscience for biomedical insights Publications Recent work highlights structural studies of glycans, antiviral heparin interactions with SARS-CoV-2 spike proteins, and inhibitor design targeting bacterial dehydrogenases. His publications span Journal of the American Chemical Society , Angewandte Chemie , and RSC Chemical Biology , reflecting interdisciplinary impact. Awards & Grants No specific awards listed, but his research has received institutional support through Keele’s Glycoscience Centre and collaborations with Manchester Institute of Biotechnology. Labs & Teams Mozilla Research Group at Keele University, part of the Glycoscience Centre, focusing on automated glycan assembly and biocatalytic processes.
